Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 6489 | 8.12 |
09:34 ET | 327 | 8.07 |
09:36 ET | 800 | 8.14 |
09:38 ET | 400 | 8.07 |
09:39 ET | 1295 | 8.05 |
09:41 ET | 1140 | 7.98 |
09:43 ET | 1200 | 7.99 |
09:45 ET | 636 | 7.99 |
09:48 ET | 3551 | 8.01 |
09:50 ET | 800 | 8.01 |
09:52 ET | 3215 | 8.01 |
09:54 ET | 3357 | 7.985 |
09:56 ET | 505 | 8.01 |
09:57 ET | 2075 | 8.01 |
09:59 ET | 3204 | 8.015 |
10:01 ET | 900 | 8.04 |
10:03 ET | 2400 | 8.0399 |
10:06 ET | 1800 | 8.025 |
10:08 ET | 5405 | 8 |
10:10 ET | 2346 | 8.02 |
10:12 ET | 907 | 8.015 |
10:14 ET | 2217 | 8.02 |
10:15 ET | 3485 | 8.0031 |
10:17 ET | 2973 | 8.005 |
10:19 ET | 1289 | 8.015 |
10:21 ET | 2112 | 8.005 |
10:24 ET | 3685 | 8.01 |
10:26 ET | 3096 | 8 |
10:28 ET | 4427 | 7.99 |
10:30 ET | 4381 | 7.97 |
10:32 ET | 1657 | 7.97 |
10:33 ET | 1700 | 7.96 |
10:35 ET | 6228 | 7.95 |
10:37 ET | 2049 | 7.97 |
10:39 ET | 300 | 7.98 |
10:42 ET | 500 | 7.97 |
10:44 ET | 2430 | 8.01 |
10:46 ET | 2721 | 8.04 |
10:48 ET | 716 | 8.07 |
10:50 ET | 900 | 8.06 |
10:51 ET | 496 | 8.06 |
10:55 ET | 730 | 8.07 |
10:57 ET | 1103 | 8.06 |
11:00 ET | 245 | 8.0669 |
11:02 ET | 1200 | 8.05 |
11:04 ET | 2922 | 8.04 |
11:06 ET | 800 | 8.04 |
11:08 ET | 437 | 8.025 |
11:09 ET | 1926 | 8.02 |
11:11 ET | 1799 | 8.0595 |
11:13 ET | 265 | 8.06 |
11:18 ET | 100 | 8.06 |
11:20 ET | 100 | 8.07 |
11:22 ET | 1214 | 8.06 |
11:24 ET | 350 | 8.06 |
11:26 ET | 6111 | 8.08 |
11:27 ET | 950 | 8.05 |
11:29 ET | 100 | 8.05 |
11:31 ET | 1200 | 8.03 |
11:33 ET | 2546 | 8.021 |
11:36 ET | 15094 | 8.02 |
11:38 ET | 718 | 8.02 |
11:40 ET | 100 | 8.03 |
11:42 ET | 321 | 8.01 |
11:44 ET | 200 | 8.02 |
11:45 ET | 1730 | 8.01 |
11:47 ET | 100 | 8.005 |
11:49 ET | 200 | 8.01 |
11:51 ET | 200 | 8.005 |
11:54 ET | 15572 | 8.015 |
11:56 ET | 1517 | 8.02 |
11:58 ET | 2084 | 8.01 |
12:00 ET | 10530 | 8.0122 |
12:02 ET | 439 | 8.005 |
12:03 ET | 100 | 8.01 |
12:07 ET | 440 | 8.005 |
12:09 ET | 5392 | 8.01 |
12:12 ET | 1325 | 8 |
12:14 ET | 2231 | 7.98 |
12:16 ET | 5956 | 7.97 |
12:18 ET | 2412 | 7.95 |
12:20 ET | 2057 | 7.94 |
12:21 ET | 1500 | 7.95 |
12:23 ET | 100 | 7.96 |
12:25 ET | 5198 | 7.955 |
12:27 ET | 9014 | 7.93 |
12:30 ET | 502 | 7.93 |
12:32 ET | 522 | 7.92 |
12:34 ET | 3239 | 7.905 |
12:36 ET | 516 | 7.9099 |
12:38 ET | 2111 | 7.93 |
12:39 ET | 500 | 7.92 |
12:41 ET | 3024 | 7.925 |
12:43 ET | 1000 | 7.91 |
12:45 ET | 300 | 7.9 |
12:48 ET | 2539 | 7.915 |
12:50 ET | 531 | 7.9101 |
12:52 ET | 100 | 7.915 |
12:54 ET | 200 | 7.915 |
12:56 ET | 6921 | 7.905 |
12:57 ET | 1140 | 7.91 |
01:01 ET | 3757 | 7.915 |
01:03 ET | 100 | 7.915 |
01:06 ET | 500 | 7.915 |
01:08 ET | 3248 | 7.9 |
01:10 ET | 906 | 7.905 |
01:12 ET | 1700 | 7.905 |
01:14 ET | 1725 | 7.905 |
01:15 ET | 608 | 7.905 |
01:17 ET | 2644 | 7.905 |
01:19 ET | 1787 | 7.905 |
01:21 ET | 2387 | 7.915 |
01:24 ET | 100 | 7.92 |
01:26 ET | 2602 | 7.925 |
01:28 ET | 6449 | 7.935 |
01:32 ET | 1000 | 7.935 |
01:33 ET | 3210 | 7.93 |
01:35 ET | 4098 | 7.955 |
01:37 ET | 2038 | 7.98 |
01:42 ET | 3095 | 8.01 |
01:44 ET | 995 | 7.995 |
01:46 ET | 2233 | 8.005 |
01:48 ET | 1519 | 7.99 |
01:50 ET | 1824 | 8 |
01:51 ET | 2383 | 8.005 |
01:53 ET | 1983 | 8.02 |
01:55 ET | 100 | 8.025 |
01:57 ET | 200 | 8.025 |
02:00 ET | 2034 | 8.02 |
02:02 ET | 3452 | 8 |
02:04 ET | 1000 | 8.01 |
02:06 ET | 2748 | 8.005 |
02:08 ET | 1135 | 7.995 |
02:09 ET | 562 | 7.98 |
02:11 ET | 937 | 7.98 |
02:13 ET | 3954 | 7.995 |
02:15 ET | 765 | 7.99 |
02:18 ET | 300 | 7.98 |
02:20 ET | 855 | 7.97 |
02:22 ET | 1037 | 7.94 |
02:24 ET | 3215 | 7.96 |
02:26 ET | 200 | 7.965 |
02:27 ET | 2651 | 7.955 |
02:29 ET | 100 | 7.96 |
02:31 ET | 701 | 7.94 |
02:33 ET | 6348 | 7.95 |
02:36 ET | 2192 | 7.955 |
02:38 ET | 1536 | 7.955 |
02:40 ET | 1092 | 7.955 |
02:42 ET | 2914 | 7.965 |
02:44 ET | 2344 | 7.98 |
02:47 ET | 5081 | 7.965 |
02:49 ET | 3804 | 7.98 |
02:51 ET | 2585 | 7.985 |
02:54 ET | 300 | 7.975 |
02:56 ET | 2120 | 7.965 |
02:58 ET | 1124 | 7.975 |
03:00 ET | 100 | 7.98 |
03:02 ET | 3147 | 7.99 |
03:03 ET | 500 | 7.98 |
03:05 ET | 2391 | 7.97 |
03:07 ET | 600 | 7.97 |
03:09 ET | 606 | 7.97 |
03:12 ET | 5610 | 7.98 |
03:14 ET | 200 | 7.985 |
03:16 ET | 5102 | 7.97 |
03:18 ET | 900 | 7.965 |
03:20 ET | 817 | 7.965 |
03:21 ET | 2902 | 7.96 |
03:23 ET | 4476 | 7.94 |
03:25 ET | 4984 | 7.955 |
03:27 ET | 100 | 7.955 |
03:30 ET | 314 | 7.951 |
03:32 ET | 4530 | 7.95 |
03:34 ET | 800 | 7.945 |
03:36 ET | 9456 | 7.94 |
03:38 ET | 1613 | 7.925 |
03:39 ET | 7692 | 7.935 |
03:41 ET | 1254 | 7.93 |
03:43 ET | 2906 | 7.925 |
03:45 ET | 963 | 7.91 |
03:48 ET | 19573 | 7.91 |
03:50 ET | 11499 | 7.915 |
03:52 ET | 2978 | 7.92 |
03:54 ET | 4078 | 7.9 |
03:56 ET | 26935 | 7.86 |
03:57 ET | 12100 | 7.855 |
03:59 ET | 245184 | 7.86 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.1B | -2.2x | --- |
Prothena Corporation PLC | 1.2B | -21.7x | --- |
Zymeworks Inc | 890.9M | -8.2x | --- |
Arcutis Biotherapeutics Inc | 1.2B | -4.7x | --- |
Silence Therapeutics PLC | 872.1M | -15.7x | --- |
Silence Therapeutics PLC | 872.1M | -14.4x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1B |
---|---|
Revenue (TTM) | $78.9M |
Shares Outstanding | 136.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $-3.58 |
Book Value | $11.80 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 14.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -715.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.